Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Monday, November 9, 2026

Back to the front page

DoorDash and Google

DoorDash and Google.

DASH $86B
Stratechery by Ben Thompson – On the business, strategy, and impact of technology. 1 click

From X

@convequity

Convequity on X

I think the Oracle credit story could look very different in 2028 and 2029 from what the market is pricing today. $ORCL has priced $10 billion of stock and $10 billion of bonds to fund its AI buildout. Management expects free cash flow to turn positive in the second half of fiscal 2028. The interesting part is how Oracle gets there. AI customers need the capacity, and those customers also have relationships with the suppliers building the infrastructure. Customer prepayments and supplier financing can move some of the funding further upstream rather than leaving Oracle to finance everything itself. I'd also watch whether support can extend further up the supply chain. The final cost of a data center is not the same as the underlying cost of the components, so there may be room for suppliers or their suppliers to provide credit backing with less exposure than the headline project value. The actual contracts and who bears losses matter here. Oracle's five-year CDS has been trading close to 300 basis points. I'm curious about the other side of that trade: who is underwriting the protection, and what happens if Oracle reaches positive free cash flow and the fear around AI infrastructure financing eases? Selling protection is still a risky bet. A premium can look attractive right up until the underlying credit deteriorates, and spreads can widen before the trade works. But if Oracle delivers the capacity and its customers pay for it, I think the picture in 2028–29 could be very different from today's gloomy consensus.

Investor Letters

All letters

NEW POSITION: Google LEAPS

Alphabet bought long-dated GOOGL calls after a 12.6% earnings drop, betting AI monetization and distribution overcome capex pressure and…

GOOGL $3.5T
Hated Moats 1 click
BAX · long

Baxter International INC

Baxter International sells IV solutions, infusion pumps and other essential medical products to hospitals, clinics and home-care providers.

BAX $13B
Value Investors Club

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 76 of 279

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.